Early initiation of diuretic therapy in patients with new onset cirrhotic ascites lowers 90-day mortality rate, according to a study in the American Journal of Gastroenterology. Researchers examined ...
J Gastroenterol Hepatol. 2009;24(9):1494-1503. Transjugular Intrahepatic Portosystemic Shunting. Transjugular intrahepatic portosystemic shunting (TIPS) creates an iatrogenic intrahepatic shunt a ...
Sequana Medical NV received premarket approval from the U.S. FDA for its Alfapump system to treat recurrent or refractory ascites due to liver cirrhosis. Data from the Poseidon pivotal study showed ...
CARSON CITY, Nev., March 13, 2023 (GLOBE NEWSWIRE) -- BioVie Inc. (BIVI), (“BioVie” or the “Company”) a clinical-stage company developing innovative drug therapies for the treatment of neurological ...
Please provide your email address to receive an email when new articles are posted on . The FDA has granted premarket approval to Sequana Medical’s alfapump implantable device for the treatment of ...
The patient underwent CT scan of the chest and abdomen. The chest CT showed only the lung lesions that are characteristic of PCP. Important cuts of the abdominal CT scan are shown in Figures 2 and 3.
Ghent, Belgium – 28 December 2023 – Sequana Medical NV (Euronext Brussels: SEQUA) (the "Company" or "Sequana Medical"), a pioneer in the treatment of fluid overload in liver disease, heart failure and ...
FORT LAUDERDALE, Fla., Dec. 31, 2024 /PRNewswire/ -- Debbie's Dream Foundation: Curing Stomach Cancer (DDF), a nonprofit dedicated to raising awareness, funding research, and supporting stomach cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback